Lupin’s ESG score rises to 76 in S&P Global ESG Ratings November 26, 2024 Global pharma major Lupin Limited (Lupin) today announced its S&P Global ESG scores have moved up to 76 from 69 last year, well above the industry average of 30 in the pharmaceuticals sector. The company has demonstrated... Trending AIIMS makes international partnership for medical research and innovation Centre issues advisory, urges states to implement preventive measures against Avian influenza Cesarean delivery rise from 17.2 % to 21.5% in five years in India Latest Eggs safe for use, cancer-risk claims misleading: FSSAI From fake-Paneer to synthetic milk: Expanding market of food fraud in India AHPI partners with UAE-based Mulk Med Healthcare to promote medical tourism Apollo Spectra unveils multirobot healthcare ecosystem in Delhi-NCR
